Patent Assignment
Reel/Frame 067660/0006
Assignment of Assignor's Interest
Recorded: 2024-06-07
Pages: 5
Assignor
FUSION ANTIBODIES PLC
Executed: 2022-03-29
Assignee
AMUNIX PHARMACEUTICALS, INC.
2 TOWER PLACE #1100, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
CD3 Antigen Binding Fragments and Compositions Comprising Same
PCT:
PCT/US2020/039673 ↗
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 29, 2021
From: MACCANN, DARRAGH; MCCLORY, JAMES
To: FUSION ANTIBODIES PLC.
Reel/Frame 055085/0581 →
Assignment of Assignor's Interest
Jan 29, 2021
From: FUSION ANTIBODIES PLC.
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 055085/0587 →
Change of Name
Feb 4, 2021
From: AMUNIX OPERATING INC.
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 055223/0978 →
Assignment of Assignor's Interest
Dec 17, 2021
From: SCHELLENBERGER, VOLKER
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 058424/0165 →
Assignment of Assignor's Interest
May 10, 2024
From: SCHELLENBERGER, VOLKER
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 067379/0148 →
Assignment of Assignor's Interest
Jun 7, 2024
From: YUMAB GMBH
To: AMUNIX PHARMACEUTICALS, INC.
Reel/Frame 067659/0897 →
Assignment of Assignor's Interest
Jun 7, 2024
From: FRENZEL, ANDRÉ; KUHN, PHILIPP
To: YUMAB GMBH
Reel/Frame 067659/0850 →